Cheng-piao Luo
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Construction of TLS-related gene signature for predicting prognosis and immunotherapy response in hepatocellular carcinoma.
Journal: Hepatology communications
Published: August 24, 2025
Tertiary lymphoid structures in HCC: Influence on immune cell profiles in tumors and on efficacy of adjuvant PD-1 inhibitor therapy after hepatectomy.
Journal: Hepatology (Baltimore, Md.)
Published: March 07, 2025
lncSNHG16 promotes hepatocellular carcinoma development by inhibiting autophagy.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: August 02, 2024
Importance of optimizing duration of adjuvant immune checkpoint inhibitor therapy to treat postoperative hepatocellular carcinoma after conversion therapy: a case report.
Journal: Journal of surgical case reports
Published: September 13, 2023
miR-17-5p slows progression of hepatocellular carcinoma by downregulating TGFβR2.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 27, 2023
Case report: Conversion therapy to permit resection of initially unresectable hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: May 17, 2022
Association of CK19 expression with the efficacy of adjuvant transarterial chemoembolization after hepatic resection in hepatocellular carcinoma patients at high risk of recurrence.
Journal: Journal of clinical and translational research
Published: November 11, 2021
The lncRNA SNHG16 affects prognosis in hepatocellular carcinoma by regulating p62 expression.
Journal: Journal of cellular physiology
Published: April 12, 2019
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients.
Journal: Journal of hepatocellular carcinoma
Published: January 25, 2017
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.
Journal: OncoTargets and therapy
Published: November 24, 2016
Soluble PD-L1 and prognosis of patients with hepatocellular carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: September 03, 2016
Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
Journal: International journal of clinical and experimental pathology
Published: October 07, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026